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Nasal or nasopharyngeal tuberculosis (TB) is rare, and the lit-
erature is limited to isolated case reports. The anatomic loca-
tion is a major field of ear, nose, and throat (ENT) specialists, 
especially rhinologists. Initial symptoms of nasal and naso-
pharyngeal TB are nonspecific, and it is, therefore, a challenge 
for rhinology specialists to diagnose rhinologic TB earlier. We 
reviewed medical records, images, and histological results be-
tween 1998 and 2014 and have found that 4 nasal TB and 8 na-
sopharyngeal TB patients were diagnosed and managed in 
Severance Hospital (Table 1). 
The mean age of the patients with nasal TB was 52.5 years. 
Most of the patients with nasal TB were middle-aged and fe-
male, similar to those in a previous report.1 Bilateral involve-
ment or the spread of TB into adjacent structures can occur in 
nasal TB because of the anatomic structure of the nasal cavi-
ty.2 In our cases, however, only 1 TB that originated in the sep-
tum spread bilaterally in the nasal cavity, making septal perfo-
ration; the other infections were localized to the primary 
infection site. It has been reported that the recurrence rate of 
nasal TB after surgical excision is greater than 50%,3 and the 
recommended medical treatment for nasal TB is the same as 
that for other category III TB lesions.2 All of our patients with 
nasal TB received medical treatment for 6 to 12 months, and 
there was no recurrence or regrowth during the average 7 year 
follow up. 
Based on previous reports, nasopharyngeal TB is slightly 
more common among females,4 and 7 out of the 8 patients 
with nasopharyngeal TB in our review were female. The mean 
age of the patients with nasopharyngeal TB was 34 years, and 
half of all the patients were in their twenties, making our pa-
tients younger overall compared with those in previous case 
reports.5 The most common symptom of nasopharyngeal TB 
in our study was otologic discomforts such as ear fullness or 
hearing impairment, although upper cervical lymphadenopa-
thy was the most common clinical presentation of nasopha-
ryngeal TB in a previous study.5 Three patients in our study re-
ceived treatment for ear symptoms such as myringotomy before 
being diagnosed with TB, which delayed the early diagnosis. 
Therefore, our results show that consideration of the possibili-
ty of nasopharyngeal TB in patients with otologic manifesta-
tions who were not responsive to conventional management 
is really important.
Nasal or nasopharyngeal TB can infect patients by two 
routes. In primary nasal or nasopharyngeal TB, the infection 
occurs directly via nasal ventilation. As a secondary route, the 
infection is transferred from another primary site through the 
airways or blood vessels.6 Four of the total 12 patients in our 
study were diagnosed also with pulmonary TB, suggesting that 
secondary nasal or nasopharyngeal TB infections were dis-
seminated from pulmonary TB infections. 
Based on our patients, imaging study such as computed to-
mography scans were not enough for the diagnosis of nasal or 
nasopharyngeal TB. Subjective symptoms such as nasal dis-
charge, obstruction, ear fullness were not helpful. We have 
found that there was no specific examination or diagnostic 
clue for nasal and nasopharyngeal TB except histologic find-
ings. Biopsy was the only confirmative tool, and tissue-based 
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Ziehl-Neelsen staining for AFB or TB PCR and histologic char-
acteristics representing granuloma enabled definite diagnosis 
of nasal and nasopharyngeal TB.7,8
Because of its rarity and nonspecific symptoms, the diagno-
sis of nasal and nasopharyngeal TB could be delayed. We sug-
gest that ENT specialists should keep in mind that nasal or 
nasopharyngeal TB is a disease entity that needs to be consid-
ered in the differential diagnosis of sino-nasal inflammatory 
diseases in South Korea, which has intermediate TB burden 
of TB, and probably in Western country, which has high inci-
dence of TB or extrapulmonary TB. 
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Table 1. Summary of the Four Patients with Nasal TB and Eight Patients with Nasopharyngeal TB
Nasal TB
Case
Age/
sex
Chief complaint Biopsy site
Pulmonary
TB
Other
EPTB
Sinus
involvement
Septal
perforation
Treatment
duration
Medication
1 68/M Nasal discharge Ethmoid sinus - TB arthritis + - 6 mo 2HERZ/4HER
2 57/F Nasal mass Nasal septum - - - + 6 mo 2HERZ/4HER
3 56/F Nasal obstruction Inferior turbinate - - - - 6 mo 2HERZ/4HER
4 29/F Nasal obstruction Nasal septum + - - - 12 mo 9HERZ/3HER
Nasopharyngeal TB
Case
Age/ 
sex
Chief complaint Biopsy site
Pulmonary
TB
Other
EPTB
Oronasal
symptom
Otologic
intervention
Treatment
duration
Medication
1 37/F Ear fullness Rosenmuller fossa + - - - 6 mo 2HERZ/4HER
2 26/F Ear fullness Lateral pharyngeal wall - - - + 6 mo 2HERZ/4HER
3 27/F Ear fullness Posterior pharyngeal wall + - - + 12 mo 2HERZ/4HER/6HR
4 39/M Hearing impairment Rosenmuller fossa - - - + 6 mo 2HERZ/4HER
5 41/F Hearing impairment Posterior pharyngeal wall - - - - 6 mo 2HERZ/4HER
6 58/F Foreign body sensation Rosenmuller fossa - - + - 6 mo 2HERZ/4HER
7 24/F Neck swelling Posterior pharyngeal wall + + + - 18 mo 5HERZ/13HER
8 27/F Sore throat Rosenmuller fossa - - + - 9 mo 2HERZ/7HER
TB, tuberculosis; EPTB, extrapulmonary tuberculosis; H, isoniazid; E, ethambutol; R, rifampin; Z, pyrazinamide.
